13F Holdings
中文EN

SKIN SkinHealth Systems Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1818093 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.4%
TTM net income YoY-55.7%
TTM EPS YoY117.5%
Revenue 3-yr CAGR-10.3%
Net income 3-yr CAGR—

Margins

Gross margin67.2%
Operating margin2.4%
Net margin-6.3%
FCF margin7.9%
EBITDA margin3.2%

Returns

ROE-30.1%
ROA-4.1%
ROIC (approx.)7.1%
Asset turnover0.65x

Leverage & solvency

Liabilities / assets85.7%
Debt / equity0.00x
Current ratio2.89x
Interest coverage0.27x

Cash quality & payout

Operating cash flow / net income-1.29x
Accruals ratio-9.4%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$300.79M$334.29M$397.99M$365.88M$260.09M
Cost of revenue$104.43M$152.00M$242.88M$117.10M$81.55M
Gross profit$196.36M$182.30M$155.11M$248.78M$178.54M
R&D expense$5.63M$6.30M$10.10M$8.44M$8.20M
SG&A expense$117.95M$125.46M$131.43M$106.10M$98.69M
Operating income-$20.80M-$67.77M-$130.92M-$25.84M-$39.93M
Interest expense$19.33M$10.41M$13.65M$13.39M$11.78M
Pretax income-$5.94M-$29.55M-$101.89M$45.34M-$380.64M
Income tax$3.58M-$452,000-$1.77M$1.11M-$1.88M
Net income-$9.52M-$29.10M-$100.12M$44.22M-$378.76M
EBITDA-$16.95M-$57.83M-$119.58M-$18.68M-$35.44M
EPS (basic)-0.08-0.23-0.760.30-3.71
EPS (diluted)-0.16-0.36-0.76-0.23-3.71
Weighted avg. shares (diluted)135.80M142.49M131.68M148.51M102.11M
Balance sheet
Cash & equivalents$232.67M$370.06M$523.02M$568.20M$901.89M
Receivables$21.74M$27.64M$54.70M$76.49M$46.82M
Inventory$48.01M$69.11M$91.32M$109.66M$35.26M
Current assets$309.52M$477.12M$698.25M$783.27M$1.00B
PP&E, net$2.54M$5.98M$14.23M$18.18M$16.18M
Goodwill$126.62M$123.50M$125.82M$124.59M$123.69M
Intangibles$35.76M$47.51M$62.12M$46.39M$56.01M
Total assets$499.80M$685.68M$929.11M$1.00B$1.22B
Current liabilities$186.28M$68.15M$115.01M$71.71M$76.44M
Long-term debt—$552.20M———
Total debt—$552.20M———
Total liabilities$438.75M$633.88M$869.72M$836.03M$916.51M
Shareholders' equity$61.06M$51.80M$59.39M$167.05M$298.03M
Net debt—$182.13M———
Shares outstanding6.38M124.92M122.90M132.21M150.60M
Cash flow statement
Operating cash flow$37.48M$16.13M$21.75M-$106.60M-$28.36M
Capital expenditure$303,000$756,000$3.83M$10.85M$11.20M
Free cash flow$37.18M$15.38M$17.93M-$117.45M-$39.56M
Investing cash flow-$5.16M-$6.79M-$31.51M-$18.87M-$37.73M
Financing cash flow-$174.93M-$158.34M-$37.45M-$205.24M$959.03M
Depreciation & amortization$3.85M$9.94M$11.33M$7.16M$4.49M
Stock-based compensation$14.82M$26.70M$22.54M$28.50M$12.42M
Share buybacks$0$0$30.16M$160.00M$0

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.